Esperion Therapeutics Inc... (ESPR)
NASDAQ: ESPR
· Real-Time Price · USD
0.80
-0.09 (-10.39%)
At close: May 09, 2025, 3:59 PM
0.80
0.24%
After-hours: May 09, 2025, 05:43 PM EDT
Esperion Therapeutics Revenue
Esperion Therapeutics reported an annual revenue of $332.31M, reflecting a 185.66% growth. For the quarter ending December 31, 2024, Esperion Therapeutics generated $69.11M in revenue.
Revenue (ttm)
$332.31M
Revenue Growth
185.66%
Price / Sales Ratio
1.24
Revenue / Employee
$1.09M
Employees
304
Market Cap
158.16M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|